Holmen Lab

Defining Critical Targets in Cancer Cells

Our lab is focused on defining critical targets in cancer cells that can become the focus for therapeutic intervention. Because of the high cost of developing new therapies, it is essential to first identify which genetic alterations can be productively targeted. We are concentrating our initial efforts on using a genetic approach in tumors that are refractory to conventional therapies including metastatic melanoma and glioblastoma. We plan to further validate these targets using pharmacological inhibitors of clinical importance.

News & Blog

4
sheri-holmen.jpg

Sheri L. Holmen, PhD
Principal Investigator
Sheri.Holmen@hci.utah.edu

Cancer Center Bio

Contact Us

Sheri Holmen
Huntsman Cancer Institute
2000 Circle of Hope, Rm 5263
Salt Lake City, UT 84112
Office: 801-213-4237